Wexford Capital LP Amicus Therapeutics, Inc. Transaction History

Wexford Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $2.14 Million - $3.42 Million	-254,797 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $708,794 - $1.01 Million	-61,103 Reduced 19.34%	254,797 $3.08 Million
Q2 2018 Aug 13, 2018	BUY	$13.13 - $17.09 $2.07 Million - $2.7 Million	157,950 Added 100.0%	315,900 $4.93 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $2.17 Million - $2.7 Million	157,950 New	157,950 $2.38 Million

311

283M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.44B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.